<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1028-9933</journal-id>
<journal-title><![CDATA[Revista Información Científica]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. inf. cient.]]></abbrev-journal-title>
<issn>1028-9933</issn>
<publisher>
<publisher-name><![CDATA[Universidad de Ciencias Médicas Guantánamo]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1028-99332018000501031</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Enfermedad de Alzheimer, algunos factores de riesgo modificables]]></article-title>
<article-title xml:lang="en"><![CDATA[Alzheimer's disease, some modifiable risk factors]]></article-title>
<article-title xml:lang="pt"><![CDATA[Doença de Alzheimer, alguns fatores de risco modificáveis]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Terrado Quevedo]]></surname>
<given-names><![CDATA[Sara Pura]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Serrano Durán]]></surname>
<given-names><![CDATA[Catalina]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Galano Guzmán]]></surname>
<given-names><![CDATA[Zulema Guadalupe]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Betancourt Pulsán]]></surname>
<given-names><![CDATA[Anselma]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Jiménez de Castro Morgado]]></surname>
<given-names><![CDATA[María Inés]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de Ciencias Médicas  ]]></institution>
<addr-line><![CDATA[ Guantánamo]]></addr-line>
<country>Cuba</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Facultad de Ciencias Médicas  ]]></institution>
<addr-line><![CDATA[ Guantánamo]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>10</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>10</month>
<year>2018</year>
</pub-date>
<volume>97</volume>
<numero>5</numero>
<fpage>1031</fpage>
<lpage>1042</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S1028-99332018000501031&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S1028-99332018000501031&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S1028-99332018000501031&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción:  la demencia es un trastorno de la cognición que interfiere en el funcionamiento de la vida diaria y produce una pérdida de la independencia. Su prevalencia e incidencia se incrementan con la edad avanzada. Se realizó una revisión bibliográfica actualizada que consistió en una búsqueda en revistas especializadas en el tema, se revisaron trabajos en idioma español e inglés y fueron incluidas investigaciones de diverso diseño de autores prestigiosos en el tema.  Objetivo:  actualizar la evidencia disponible sobre los factores de riesgo modificables que se asocian a la enfermedad de Alzheimer (EA).  Desarrollo:  en las últimas décadas, los estudios epidemiológicos revelan varios factores de riesgo para el desarrollo de esta entidad, entre los que aparecen los factores relacionados con el estilo de vida. Estrategias poblacionales de modificación de estos factores podrían potencialmente evitar algunos casos de Alzheimer.  Conclusiones:  las estrategias poblacionales deben comprender un esfuerzo global que involucre población supuestamente saludable, profesionales de la salud, y la comunidad, para modificar el modo y estilo de vida dirigida a los factores modificables, de manera que contribuyan al conocimiento de la enfermedad a su manejo y al retardo de su aparición.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction:  dementia is a disorder of cognition that interferes with the functioning of daily life and produces a loss of independence. Its prevalence and incidence increase with advanced age. An updated bibliographical review was carried out, which consisted of a search of specialized journals on the subject, works in Spanish and English were reviewed, and investigations of diverse design by prestigious authors on the subject were included.  Objective:  to update the available evidence on the modifiable risk factors associated with Alzheimer's disease (AD).  Development:  in recent decades, epidemiological studies reveal several risk factors for the development of this entity, among which appear the factors related to lifestyle. Population strategies for modifying these factors could potentially prevent some cases of Alzheimer's.  Conclusions:  Population strategies must include a global effort involving the supposedly healthy population, health professionals, and the community, to modify the way and style of life directed to the modifiable factors, so that they contribute to the knowledge of the disease to its management and the delay of its appearance.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[RESUMO  Introdução:  a demência é um distúrbio da cognição que interfere no funcionamento da vida cotidiana e produz uma perda de independência. Sua prevalência e incidência aumentam com a idade avançada. Realizou-se uma revisão bibliográfica atualizada, que consistiu na busca de periódicos especializados sobre o tema, trabalhos em espanhol e inglês, além de investigações de desenho diversificado por prestigiados autores sobre o assunto.  Objetivo:  atualizar as evidências disponíveis sobre os fatores de risco modificáveis associados à doença de Alzheimer (DA).  Desenvolvimento:  nas últimas décadas, estudos epidemiológicos revelam vários fatores de risco para o desenvolvimento dessa entidade, dentre os quais aparecem os fatores relacionados ao estilo de vida. Estratégias populacionais para modificar esses fatores poderiam potencialmente prevenir alguns casos de Alzheimer.  Conclusões:  As estratégias populacionais devem incluir um esforço global envolvendo a população supostamente saudável, os profissionais de saúde e a comunidade, para modificar o modo e o estilo de vida direcionados aos fatores modificáveis, de modo que contribuam para o conhecimento da doença até o seu desenvolvimento. gestão e o atraso do seu aparecimento.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Alzheimer]]></kwd>
<kwd lng="es"><![CDATA[riesgo modificable]]></kwd>
<kwd lng="es"><![CDATA[estrategia poblacional]]></kwd>
<kwd lng="en"><![CDATA[Alzheimer's]]></kwd>
<kwd lng="en"><![CDATA[modifiable risk]]></kwd>
<kwd lng="en"><![CDATA[population strategy]]></kwd>
<kwd lng="pt"><![CDATA[Alzheimer]]></kwd>
<kwd lng="pt"><![CDATA[risco modificável]]></kwd>
<kwd lng="pt"><![CDATA[estratégia populaciona]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Niu]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Alvarez Alvarez]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Guillén Grima]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Aguinaga Ontoso]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalencia e incidencia de la enfermedad de Alzheimer en Europa: metaanálisis]]></article-title>
<source><![CDATA[Neurología]]></source>
<year>2016</year>
<volume>32</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>523-32</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<collab>Biblioteca Médica Nacional</collab>
<article-title xml:lang=""><![CDATA[Enfermedad de Alzheimer. Calidad de Vida]]></article-title>
<source><![CDATA[Bibliomed]]></source>
<year>2016</year>
<volume>23</volume>
<numero>12</numero>
<issue>12</issue>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vom Berg]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Prokop]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Miller]]></surname>
<given-names><![CDATA[KR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Inhibition of IL-12/IL-23 signaling reduces Alzheimer&amp;apos;s disease-like pathology and cognitive decline]]></article-title>
<source><![CDATA[Nat Med]]></source>
<year>2012</year>
<volume>18</volume>
<page-range>181</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Oppmann]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Lesley]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Blom]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12]]></article-title>
<source><![CDATA[Immunity]]></source>
<year>2000</year>
<volume>13</volume>
<page-range>715-25</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vlad]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
<name>
<surname><![CDATA[Miller]]></surname>
<given-names><![CDATA[DR]]></given-names>
</name>
<name>
<surname><![CDATA[Kowall]]></surname>
<given-names><![CDATA[NW]]></given-names>
</name>
<name>
<surname><![CDATA[Felson]]></surname>
<given-names><![CDATA[DT]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Protective effects of NSAIDs on the development of Alzheimer disease]]></article-title>
<source><![CDATA[Neurology]]></source>
<year>2008</year>
<volume>70</volume>
<page-range>1672-7</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rocca]]></surname>
<given-names><![CDATA[WA]]></given-names>
</name>
<name>
<surname><![CDATA[Amaducci]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
<name>
<surname><![CDATA[Schoemberg]]></surname>
<given-names><![CDATA[BS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiology of clinically diagnosed Alzheimer disease]]></article-title>
<source><![CDATA[Ann Neurol]]></source>
<year>1998</year>
<volume>19</volume>
<page-range>415-24</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Qiu]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Ronchi de]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Fratiglioni]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The epidemiology of the dementias an update]]></article-title>
<source><![CDATA[Curr Opin Psychiatry]]></source>
<year>2007</year>
<volume>20</volume>
<page-range>380-5</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Launer]]></surname>
<given-names><![CDATA[Lj]]></given-names>
</name>
<name>
<surname><![CDATA[Andersen]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Dewey]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Rates and risk factors for dementia and Alzheimer&amp;apos;s disease: Results from EURODEM pooled analyses]]></article-title>
<source><![CDATA[Neurology]]></source>
<year>1999</year>
<volume>52</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>78-84</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Barnes]]></surname>
<given-names><![CDATA[DE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Projected Impact of Risk Factor Reduction on Alzheimer's Disisease Prevalence]]></article-title>
<source><![CDATA[Lancet Neurol]]></source>
<year>2011</year>
<volume>10</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>819-28</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hsu]]></surname>
<given-names><![CDATA[DC]]></given-names>
</name>
<name>
<surname><![CDATA[Marshall]]></surname>
<given-names><![CDATA[GA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Primary and Secondary Prevention Trials in Alzheimer Disease: Looking Back, Moving Forward]]></article-title>
<source><![CDATA[Curr Alzheimer Res]]></source>
<year>2017</year>
<volume>14</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>426-40</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Solórzano Romero]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factores de riesgo de la enfermedad de Alzheimer]]></article-title>
<source><![CDATA[Rev Hosp Psiq Hab]]></source>
<year>2014</year>
<volume>11</volume>
<numero>3</numero>
<issue>3</issue>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Moore]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Miskovski]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Stupar]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ng]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<source><![CDATA[Reducing the Prevalence of Alzheimer's Disease: modifible risk factors or social determinants of health]]></source>
<year>2015</year>
<publisher-loc><![CDATA[Sydney ]]></publisher-loc>
<publisher-name><![CDATA[Alzheimer's Australia NSW]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sandra]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pope Will a healthy lifestyle help prevent Alzheimer's disease?]]></article-title>
<source><![CDATA[Annu Rev Pub Health [en línea]]]></source>
<year>2003</year>
<volume>24</volume>
<page-range>111-32</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sofi]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Valecchi]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Bacci]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Abbate]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Gensini]]></surname>
<given-names><![CDATA[GF]]></given-names>
</name>
<name>
<surname><![CDATA[Casini]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Physical activity and risk of cognitive decline a meta-analysis of prospective studies]]></article-title>
<source><![CDATA[J Intern Med]]></source>
<year>2011</year>
<volume>269</volume>
<page-range>107-17</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ngandu]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Lehtisalo]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Solomon]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Levalahti]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Ahtiluoto]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Antikainen]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER) a randomized con-trolled trial]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2015</year>
<volume>385</volume>
<page-range>2255-63</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Menéndez González]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Estilo de vida y riesgo de padecer demencia]]></article-title>
<source><![CDATA[Arch Med]]></source>
<year>2011</year>
<volume>7</volume>
<numero>31</numero>
<issue>31</issue>
</nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Flicker]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Modifiable Lifestyle Risk Factors for Alzheimer's Disease]]></article-title>
<source><![CDATA[J Alzheimer's Dis]]></source>
<year>2010</year>
<volume>20</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>803-11</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martín]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<source><![CDATA[Nutrición y demencia - resumen ejecutivo]]></source>
<year>2014</year>
<publisher-loc><![CDATA[Londres ]]></publisher-loc>
<publisher-name><![CDATA[Alzheimer's Disease International (ADI)]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carnero Pardo]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Escamilla Sevilla]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA["Enfermedad de Alzheimer: factores de riesgo y protectores"]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Martínez Lage]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Berthier Torres]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA["Alzheimer 2002: teoría y práctica"]]></source>
<year>2002</year>
<publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[Aula Médica Ediciones]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dudkowiak]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Gryglas]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Poniewierka]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The role of diet and antioxidants in the prevention of Alzheimer's disease]]></article-title>
<source><![CDATA[J Med Sci]]></source>
<year>2016</year>
<volume>85</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>205-12</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Caballer García]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Los ácidos grasos omega-3 en la prevención de la enfermedad de Alzheimer]]></article-title>
<source><![CDATA[Alzheimer Real Invest Demenc]]></source>
<year>2011</year>
<volume>49</volume>
<page-range>12-8</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rodrigo Valenzuela]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ácido Docohexanoico (DHA): Una perspectiva nutricional para la prevención de la Enfermedad de Alzheimer]]></article-title>
<source><![CDATA[Rev Chil Nutr]]></source>
<year>2008</year>
<volume>35</volume>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
<page-range>250-61</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yassine]]></surname>
<given-names><![CDATA[HN]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Association of Docosahexaenoic Acid Supplementation with Alzheimer Disease Stage in Apolipoprotein E e4 Carriers a Review]]></article-title>
<source><![CDATA[JAMA Neurol]]></source>
<year>2017</year>
<volume>74</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>339-47</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cruz-Tioba]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Efecto antioxidante de flavonoides contra la toxicidad del amiloide-ß fracción 25-35: modelo conductual de Alzheimer]]></article-title>
<source><![CDATA[Arch Neuroc]]></source>
<year>2005</year>
<volume>10</volume>
<numero>23</numero>
<issue>23</issue>
</nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Escamilla Jiménez]]></surname>
<given-names><![CDATA[CI]]></given-names>
</name>
<name>
<surname><![CDATA[Cuevas Martínez]]></surname>
<given-names><![CDATA[EY]]></given-names>
</name>
<name>
<surname><![CDATA[Fonseca]]></surname>
<given-names><![CDATA[JG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Flavonoides y sus acciones antioxidantes]]></article-title>
<source><![CDATA[Rev Fac Med UNAM]]></source>
<year>2009</year>
<volume>52</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>73-5</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
